Patients with GOG performance status of 3 or 4
Patients with GOG performance grade of 3 or 4
Patients with a GOG performance status of 0, 1, or 2
Have performance status of 0 or 1 on the GOG performance scale
Patients with GOG performance grade of 3 or 4
PHASE II: Patients must have a GOG performance status of 0, 1, or 2
Patients with a GOG Performance Status of 0, 1, or 2.
Gynecological Oncology Group (GOG) performance status =< 2
Patients who have received one prior regimen must have a GOG performance status of 0, 1 or 2; patients who have received two or more prior regimens must have GOG performance status of 0 or 1
Patients with GOG performance status of 3 or 4
Patients must have a GOG performance status of 0 or 1
Patients with GOG performance status of 2, 3 or 4; or ECOG performance status of 2, 3 or 4
Patients must have a GOG performance status of 0 or 1.
GOG performance status 0-2;
Patients with GOG performance grade of 3 or 4
Patients must have a GOG performance status of 0 or 1
Patients must have a Gynecological Oncology Group (GOG) performance status of 0, 1 or 2
Patients with a GOG performance status of grade 3 or 4 are not eligible
GOG performance status 0-2 (refer to Appendix A);
Patients with a GOG Performance Status of 0, 1, or 2
Patients with GOG performance grade of 3 or 4
GOG performance status > 2
Performance status 0, 1 or 2
WHO performance status of 0 or 1
Performance Status of 0, 1, or 2
Performance status of 0 or 1
Performance status of 0 or 1
Performance status 0-1.
Adequate Performance Status
Performance status =< 2
Patient has a WHO performance status 0-1
Performance status of 0-3
Performance status of 0, 1, or 2
Good performance status
Performance status of 0 to 3
Performance status =< 3
Performance status =< 1
Performance status of 0 or 1
Performance status of 0-3
Performance status of 0, 1, or 2
WHO Performance Status 0, 1 or 2. A maximum of 1/3 of patients in cohorts A & B may be WHO performance status 2
Must have adequate performance status:
Performance status of 0, 1, or 2
Performance status =< 2
Performance status 0-2
Performance status >= 60%
Performance status >= 2
Performance status will not be considered
Performance status =< 3
WHO performance status 0-1
Performance status 0-1
Performance status of 0 or 1
Performance Status:
Performance status 0-1
Kamofsky performance status ?70%
Performance Status 0-2;
Performance Status 0-1
Performance status must be 0-1.
Patients with any performance status are eligible for enrollment
WHO performance status of 3 or 4
Performance status 0 or 1
WHO performance status 0-2
Performance status >= 60%
Performance status 0-1
WHO performance status of ? 1
Performance status of 0, 1, or 2
Adequate performance status.
Adequate performance status, defined as:
Performance status:
Performance Status of 0 or 1
Performance Status of 0 or 1.
WHO performance status of 0-1
Performance Status of 0 or 1
WHO performance status of ? 2.
Performance Status of 0 or 1
WHO performance status 0-1.
Performance status 0-2
Acceptable level of performance status (both)
Performance status of 2 or better
Performance status of 0 - 1
Patients must have a performance status of 0-2
Performance status =< 1
Performance status 0 or 1
performance status of 0 or 1
Performance status as per protocol
Gynecologic Oncology Group (GOG) performance status 0, 1, 2
Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
Patients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists; in general, this would refer to any active GOG Phase III protocol or Rare Tumor protocol for the same patient population
Patients must have a Gynecologic Oncology Group (GOG) performance grade of 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status > 2
Gynecologic Oncology Group (GOG) or Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky scale (KPS) =< 70%
Eastern Cooperative Oncology Group (ECOG) (World Health Organization [WHO]/Gynecologic Oncology Group [GOG]/Zubrod score) performance status 0 - 2
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status =< 2
PHASE I: Patients must have a Gynecologic Oncology Groups (GOG) performance status of 0, 1, or 2
Unlimited number of prior treatment lines, provided Gynecologic Oncology Group (GOG)/Eastern Cooperative Oncology Group (ECOG) status is 0-1
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0 or 1
Gynecologic Oncology Group (GOG) performance status =< 2
Gynecologic Oncology Group (GOG) Performance Status of 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status >= 2
Gynecologic Oncology Group (GOG) performance status of 0 or 1
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0-1
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients with Gynecologic Oncology Group (GOG) performance status of 3 or 4
Gynecologic Oncology Group (GOG) performance status of 0 to 1.
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients must not be eligible for a higher priority NRG clear cell protocol (Gynecologic Oncology Group [GOG]-0283); rare patients ineligible for GOG-0283 may be eligible for this trial without prior treatment on dasatinib therapy (e.g. they have been deemed allergic to dasatinib)
Gynecologic Oncology Group (GOG) performance status =< 2
Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2
Patients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists            \r\n* In general, this would refer to any active GOG phase III or rare tumor protocol for the same patient population
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Peritoneal dialysis catheter implantation is identical to that from the Gynecologic Oncology Group (GOG) 252 Protocol and revised from the GOG Surgical Procedures Manual
Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patient must have Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2
Patients must have a Gynecologic Oncology Group (GOG) performance grade of 0, 1, or 2
Gynecologic Oncology Group (GOG) performance status =< 2